These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 20925517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 3. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G, O'Brien TP.
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED, Comstock TL, Proksch JW.
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
    Yoshida J, Kim A, Pratzer KA, Stark WJ.
    J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
    [Abstract] [Full Text] [Related]

  • 8. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW, Ward KW.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
    Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG.
    Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles.
    Jain GK, Jain N, Pathan SA, Akhter S, Talegaonkar S, Chander P, Khar RK, Ahmad FJ.
    J Pharm Biomed Anal; 2010 May 01; 52(1):110-3. PubMed ID: 20045276
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V.
    J Cataract Refract Surg; 2008 Aug 01; 34(8):1379-82. PubMed ID: 18655991
    [Abstract] [Full Text] [Related]

  • 14. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
    Güngör SG, Akova YA, Bozkurt A, Yasar Ü, Babaoğlu MÖ, Çetinkaya A, Çolak M.
    Br J Ophthalmol; 2011 Sep 01; 95(9):1272-5. PubMed ID: 21030410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB, Protzko EE, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL, Usner DW.
    Ophthalmology; 2009 Sep 01; 116(9):1615-1623.e1. PubMed ID: 19643483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M, Yamada M, Kinoshita S, Inatomi T, Ohashi Y, Uno T, Shimazaki J, Satake Y, Maeda N, Hori Y, Nishida K, Kubota A, Nakazawa T, Shimomura Y.
    Adv Ther; 2012 Apr 01; 29(4):339-49. PubMed ID: 22529026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.